Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Ross · SciRah

Researcher profile · Semantic Scholar

D. Ross

Share profile

D. Ross — researcher profile on SciRah

h-index: 37
Works: 104
Citations: 6,256

Most-cited papers

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
L. Doyle, D. Ross
2003Oncogene1,117 citations
Semantic Scholar
The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme*
Partha Krishnamurthy, D. Ross, T. Nakanishi, Kim Bailey-Dell +5 more
2004Journal of Biological Chemistry689 citations Open access
Semantic Scholar
Role of Breast Cancer Resistance Protein (BCRP/ABCG2) in Cancer Drug Resistance
K. Natarajan, Yi Xie, M. Baer, D. Ross
2012Biochemical Pharmacology408 citations Open access
Semantic Scholar
Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.
Zhe-Sheng Chen, R. Robey, M. Belinsky, I. Shchaveleva +5 more
2003Cancer Research321 citations
Semantic Scholar
Identification of a Novel Estrogen Response Element in the Breast Cancer Resistance Protein (ABCG2) Gene
P. Ee, S. Kamalakaran, D. Tonetti, Xiaolong He +2 more
2004Cancer Research236 citations
Semantic Scholar
Novel mechanisms of drug resistance in leukemia
D. Ross
2000Leukemia211 citations Open access
Semantic Scholar
The 44-kDa Pim-1 Kinase Phosphorylates BCRP/ABCG2 and Thereby Promotes Its Multimerization and Drug-resistant Activity in Human Prostate Cancer Cells*
Ying-Qiu Xie, Ke-Xin Xu, Douglas E. Linn, Xi Yang +8 more
2008Journal of Biological Chemistry204 citations Open access
Semantic Scholar
Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression.
T. Nakanishi, Ken Shiozawa, B. Hassel, D. Ross
2006Blood158 citations
Semantic Scholar
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma.
Tamer E. Fandy, S. Shankar, D. Ross, E. Sausville +1 more
2005Neoplasia156 citations Open access
Semantic Scholar
Aryl Hydrocarbon Receptor Is a Transcriptional Activator of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
Kah Poh Tan, Bernice Wang, Ming-Dong Yang, P. Boutros +10 more
2010Molecular Pharmacology133 citations
Semantic Scholar
Erratum: A multidrug resistance transporter from human MCF-7 breast cancer cells (Proceedings of the National Academy of Sciences of the USA (December 22, 1998) 95 (15665-15670))
L. Doyle, Wei-Tse Yang, L. Abruzzo, T. Krogmann +3 more
1999128 citations
Semantic Scholar
Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic
Ken Shiozawa, M. Oka, H. Soda, M. Yoshikawa +11 more
2004International Journal of Cancer115 citations Open access
Semantic Scholar
Progesterone Receptor (PR) Isoforms PRA and PRB Differentially Regulate Expression of the Breast Cancer Resistance Protein in Human Placental Choriocarcinoma BeWo Cells
Honggang Wang, Eun-Woo Lee, Lin Zhou, P. Leung +3 more
2008Molecular Pharmacology113 citations
Semantic Scholar
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan
Anshul Gupta, Yang Dai, R. R. Vethanayagam, M. Hebert +4 more
2006Cancer Chemotherapy and Pharmacology109 citations
Semantic Scholar
The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.
Yue-Xing Zhang, Xin-Wei Wang, D. Jelovac, T. Nakanishi +6 more
2005Proceedings of the National Academy of Sciences of the United States of America94 citations Open access
Semantic Scholar
Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
J. Karp, D. Ross, Wei-Dong Yang, Michael L. Tidwell +6 more
2003Clinical Cancer Research88 citations
Semantic Scholar
Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.
Xue-Ke Fan, D. Ross, H. Arakawa, V. Ganapathy +2 more
2010Biochemical Pharmacology83 citations
Semantic Scholar
Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference.
P. L. Rachel Ee, Xiaolong He, D. Ross, W. T. Beck
2004Molecular Cancer Therapeutics82 citations
Semantic Scholar
Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-d-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias
J. Karp, A. Passaniti, I. Gojo, S. Kaufmann +11 more
2005Clinical Cancer Research79 citations
Semantic Scholar
Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients.
T. Nakanishi, J. Karp, Ming T. Tan, L. Doyle +4 more
2003Clinical Cancer Research79 citations
Semantic Scholar
Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
S. Shankar, T. R. Singh, Tamer E. Fandy, T. Luetrakul +2 more
2005International Journal of Molecular Medicine78 citations
Semantic Scholar
Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines
T. Efferth, A. Sauerbrey, M. Halatsch, D. Ross +1 more
2002Naunyn-Schmiedeberg's Archives of Pharmacology77 citations
Semantic Scholar
A Novel Xenobiotic Responsive Element Regulated by Aryl Hydrocarbon Receptor is Involved in the Induction of BCRP/ABCG2 in LS174T cells
Leslie M. Tompkins, Haishan Li, Lin-Hao Li, Caitlin Lynch +4 more
2010Biochemical Pharmacology75 citations Open access
Semantic Scholar
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function
A. Suvannasankha, H. Minderman, K. O'Loughlin, T. Nakanishi +3 more
2004Leukemia73 citations Open access
Semantic Scholar
Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
T. Nakanishi, Kim Bailey-Dell, B. Hassel, Ken Shiozawa +3 more
2006Cancer Research72 citations
Semantic Scholar
Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.
Rajeev Rajendra, M. Gounder, A. Saleem, J. Schellens +4 more
2003Cancer Research72 citations
Semantic Scholar
Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias
Ken Shiozawa, T. Nakanishi, M. Tan, Hong-Bin Fang +6 more
2009Clinical Cancer Research68 citations Open access
Semantic Scholar
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease‐free survival
A. Suvannasankha, H. Minderman, K. O'Loughlin, T. Nakanishi +5 more
2004British Journal of Haematology62 citations
Semantic Scholar
Activity of ascaridol from the anthelmintic herb Chenopodium anthelminticum L. against sensitive and multidrug-resistant tumor cells.
T. Efferth, A. Olbrich, A. Sauerbrey, D. Ross +2 more
2002Anticancer Research62 citations
Semantic Scholar
Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice
S. Shankar, Rachel Davis, Karan P. Singh, R. Kurzrock +2 more
2009Molecular Cancer Therapeutics57 citations Open access
Semantic Scholar
Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome.
D. Ross
2004Baillière's Best Practice & Research: Clinical Haematology56 citations
Semantic Scholar
Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp).
A. Aszalós, K. Thompson, J.-J. Yin, D. Ross
1999Anticancer Research54 citations
Semantic Scholar
Impact of breast cancer resistance protein on cancer treatment outcomes.
D. Ross, T. Nakanishi
2010Methods in molecular biology52 citations
Semantic Scholar
Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs.
A. Aszalos, D. Ross
1998Anticancer Research51 citations
Semantic Scholar
Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia
I. Gojo, M. Tan, Hong-Bin Fang, M. Sadowska +8 more
2013Clinical Cancer Research46 citations Open access
Semantic Scholar
Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients
N. Takebe, Xiangfei Cheng, Suhlan Wu, K. Bauer +9 more
2004Clinical Cancer Research41 citations Open access
Semantic Scholar
Experimental design and interaction analysis of combination studies of drugs with log‐linear dose responses
Hong-Bin Fang, D. Ross, E. Sausville, Ming T. Tan
2008Statistics in Medicine39 citations
Semantic Scholar
Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
D. Ross, S. Akman, A. Schrecker, N. Bachur
1981Cancer Research37 citations
Semantic Scholar
Variation amongst K562 cell cultures.
I. Dimery, D. Ross, J. Testa, S. Gupta +3 more
1983Experimental Hematology31 citations
Semantic Scholar
Identification of gene expression profiles predicting tumor cell response to L-alanosine.
T. Efferth, E. Gebhart, D. Ross, A. Sauerbrey
2003Biochemical Pharmacology30 citations
Semantic Scholar
Interaction of N,N',N''-triethylenethiophosphoramide and N,N',N''-triethylenephosphoramide with cellular DNA.
N. A. Cohen, Merrill J. Egorin, S. Snyder, B. Ashar +4 more
1991Cancer Research26 citations
Semantic Scholar
Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
A. Wu, Pooja S. Dalvi, Xiao-Li Lu, Ming-Dong Yang +6 more
2013Molecular Pharmacology25 citations
Semantic Scholar
A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia.
K. Bauer, J. Karp, T. Garimella, Suhlan Wu +2 more
2005Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis24 citations
Semantic Scholar
Drug efflux by Breast Cancer Resistance Protein (BCRP) is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924
X. Hou, Fei Huang, J. Carboni, K. Flatten +9 more
2011Molecular Cancer Therapeutics22 citations Open access
Semantic Scholar
Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-β*
P. Gade, Amy S. Kimball, A. D. DiNardo, Priyamvada Gangwal +4 more
2016Journal of Biological Chemistry21 citations Open access
Semantic Scholar
Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine.
K. Natarajan, Yi Xie, T. Nakanishi, W. T. Beck +2 more
2011Biochimica et Biophysica Acta21 citations Open access
Semantic Scholar
Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPL
Tamer E. Fandy, D. Ross, S. Gore, R. K Srivastava
2007Cancer Chemotherapy and Pharmacology21 citations
Semantic Scholar
Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells
Yi Xie, T. Nakanishi, K. Natarajan, Lowell Safren +3 more
2015Biochimica et Biophysica Acta20 citations Open access
Semantic Scholar
Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells
P. Lenehan, P. Gutierrez, J. Wagner, Niteen Milak +2 more
2009Cancer Chemotherapy and Pharmacology20 citations
Semantic Scholar
Cellular and pharmacologic aspects of drug resistance in acute myeloid leukemia
D. Ross
1991Current Opinion in Oncology18 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Nakanishi×16
Invite
T. Nakanishi — researcher profile on SciRah
R. K Srivastava×5
Invite
R. K Srivastava — researcher profile on SciRah
Ken Shiozawa×4
Invite
Ken Shiozawa — researcher profile on SciRah
J. Karp×4
Invite
J. Karp — researcher profile on SciRah

×4

Invite

K. Bauer — researcher profile on SciRah

Invite

L. Doyle — researcher profile on SciRah

K. Natarajan×3

Invite

K. Natarajan — researcher profile on SciRah

Invite

Yi Xie — researcher profile on SciRah

Invite

M. Baer — researcher profile on SciRah

Invite

W. T. Beck — researcher profile on SciRah

Tamer E. Fandy×3

Invite

Tamer E. Fandy — researcher profile on SciRah

Invite

S. Shankar — researcher profile on SciRah